215 related articles for article (PubMed ID: 24378987)
1. Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation.
Oltmann SC; Schneider DF; Leverson G; Sivashanmugam T; Chen H; Sippel RS
Ann Surg Oncol; 2014 Apr; 21(4):1379-83. PubMed ID: 24378987
[TBL] [Abstract][Full Text] [Related]
2. Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma.
Song JSA; Moolman N; Burrell S; Rajaraman M; Bullock MJ; Trites J; Taylor SM; Rigby MH; Hart RD
Head Neck; 2018 Oct; 40(10):2129-2136. PubMed ID: 29756327
[TBL] [Abstract][Full Text] [Related]
3. Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation.
Ahn J; Jeon MJ; Song E; Kim TY; Kim WB; Shong YK; Kim WG
Endocrinol Metab (Seoul); 2020 Mar; 35(1):115-121. PubMed ID: 32207271
[TBL] [Abstract][Full Text] [Related]
4. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.
Hölzer S; Reiners C; Mann K; Bamberg M; Rothmund M; Dudeck J; Stewart AK; Hundahl SA
Cancer; 2000 Jul; 89(1):192-201. PubMed ID: 10897018
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
Xu B; Tallini G; Scognamiglio T; Roman BR; Tuttle RM; Ghossein RA
Thyroid; 2017 Apr; 27(4):512-517. PubMed ID: 28136139
[TBL] [Abstract][Full Text] [Related]
6. Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function.
Tuttle RM; Lopez N; Leboeuf R; Minkowitz SM; Grewal R; Brokhin M; Omry G; Larson S
Thyroid; 2010 Mar; 20(3):257-63. PubMed ID: 20187781
[TBL] [Abstract][Full Text] [Related]
7. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
8. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
[TBL] [Abstract][Full Text] [Related]
10. Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
Prasad PK; Mahajan P; Hawkins DS; Mostoufi-Moab S; Venkatramani R
Pediatr Blood Cancer; 2020 Jun; 67(6):e28141. PubMed ID: 32275118
[TBL] [Abstract][Full Text] [Related]
11. Role of [
Xu Q; Liu R; Wang J; Huang Y; Li S; Zhang L; Wang F
Nucl Med Biol; 2020; 88-89():34-43. PubMed ID: 32688289
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine remnant ablation in papillary thyroid microcarcinoma: a meta-analysis.
Yang T; Zheng SY; Jiao J; Zou Q; Zhang Y
Nucl Med Commun; 2019 Jul; 40(7):711-719. PubMed ID: 31095043
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
14. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
Scheffel RS; Zanella AB; Dora JM; Maia AL
Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
[TBL] [Abstract][Full Text] [Related]
15. The relationship between extent of thyroid cancer surgery and use of radioactive iodine.
Haymart MR; Banerjee M; Yang D; Stewart AK; Doherty GM; Koenig RJ; Griggs JJ
Ann Surg; 2013 Aug; 258(2):354-8. PubMed ID: 23567930
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Low-dose and High-dose Radioactive Iodine Ablation With rhTSH in Korean Patients With Differentiated Thyroid Carcinoma: The First Report in Nonwestern Countries.
Joung JY; Choi JH; Cho YY; Kim NK; Sohn SY; Kim SW; Chung JH
Am J Clin Oncol; 2016 Aug; 39(4):374-8. PubMed ID: 24732812
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis.
Lang BH; Wong KP; Cheung CY; Wan KY; Lo CY
Ann Surg Oncol; 2013 Apr; 20(4):1329-35. PubMed ID: 23104708
[TBL] [Abstract][Full Text] [Related]
18. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
19. RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system.
Zeuren R; Biagini A; Grewal RK; Randolph GW; Kamani D; Sabra MM; Shaha AR; Tuttle RM
Laryngoscope; 2015 Oct; 125(10):2417-24. PubMed ID: 25891354
[TBL] [Abstract][Full Text] [Related]
20. Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients' Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial.
Jammah AA; Masood A; Akkielah LA; Alhaddad S; Alhaddad MA; Alharbi M; Alguwaihes A; Alzahrani S
Front Endocrinol (Lausanne); 2020; 11():603432. PubMed ID: 33716951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
